Clincosm LogoSign in Get a demo

metastatic malignant melanoma

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Malignant Melanoma Trial in Oslo (Dendritic cells - transfected with hTERT-, survivin- and tumor cell derived mRNA +

Terminated
  • Metastatic Malignant Melanoma
  • Dendritic cells - transfected with hTERT-, survivin- and tumor cell derived mRNA + ex vivo T cell expansion and reinfusion
  • Temozolomide
  • Oslo, Montebello, Norway
    The Norwegian Radium Hospital, Department of Clinical Cancer Res
Feb 23, 2021

Metastatic Malignant Melanoma Trial in Montreal (Pembrolizumab, Carboplatin, Paclitaxel)

Active, not recruiting
  • Metastatic Malignant Melanoma
  • Montreal, Quebec, Canada
  • +1 more
Feb 17, 2021

Metastatic Malignant Melanoma, Unresectable Malignant Melanoma Trial in Bergen (Bevacizumab, Propranolol, Enalapril)

Terminated
  • Metastatic Malignant Melanoma
  • Unresectable Malignant Melanoma
  • Bergen, Norway
    Haukeland University Hospital
Feb 23, 2017

Metastatic Malignant Melanoma Trial in Italy (Ipilimumab and Fotemustine)

Completed
  • Metastatic Malignant Melanoma
  • Ipilimumab and Fotemustine
  • Genoa, Italy
  • +6 more
May 12, 2015

Metastatic Malignant Melanoma Trial (Autologous cytokines)

Completed
  • Metastatic Malignant Melanoma
  • Autologous cytokines
  • (no location specified)
Jan 26, 2015

Metastatic Malignant Melanoma Trial in United States (IMC-1121B (ramucirumab), Dacarbazine)

Completed
Has Results
  • Metastatic Malignant Melanoma
  • Decatur, Alabama
  • +16 more
Jul 29, 2014

Metastatic Malignant Melanoma Trial in San Francisco, Santa Monica (Avastin, Abraxane)

Completed
Has Results
  • Metastatic Malignant Melanoma
  • San Francisco, California
  • +1 more
Jan 7, 2014

Metastatic Renal Cell Carcinoma, Metastatic Malignant Melanoma Trial in Auckland, Hamilton, London (AS1409)

Completed
  • Metastatic Renal Cell Carcinoma
  • Metastatic Malignant Melanoma
  • Auckland, New Zealand
  • +3 more
Aug 24, 2009

Metastatic Malignant Melanoma Trial in San Francisco (Temozolomide and SU11248)

Terminated
  • Metastatic Malignant Melanoma
  • Temozolomide and SU11248
  • San Francisco, California
    Northern California Melanoma Center
Feb 3, 2009